loading

  • Strategic Report
  • Our Governance
  • Our Financials
  • Shareholder Information
  • Welcome to Dechra Pharmaceuticals PLC
  • The Global Market Opportunity
  • Dechra's Strengths
  • Highlights
  • Our Business Model
  • Our Business Model Explained
  • Our Products
  • Delivering Our Strategy
  • Geographical Footprint
  • Non-Executive Chairman's and Chief Executive Officer's Statement
  • Financial Review
  • Q&A with Ian Page
  • Q&A with Richard Cotton
  • Key Performance Indicators
  • Strategy in Action
  • Product Development
  • International Product Offering
  • Corporate Social Responsibility
  • How the Business Manages Risk
  • Understanding Our Key Risks
  • Letter from the Chairman on Governance
  • Corporate Governance
  • Letter from the Audit Committee Chairman
  • Audit Committee Report
  • Letter from the Nomination Committee Chairman
  • Letter from the Remuneration Committee Chairman
  • Directors' Remuneration Report
  • Directors' Report - Other Disclosures
  • Statement of Directors' Responsibilities
  • Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC
  • Consolidated Income Statement
  • Consolidated Statement of Comprehensive Income
  • Consolidated Statement of Financial Position
  • Consolidated Statement of Changes in Shareholders' Equity
  • Consolidated Statement of Cash Flows
  • Notes to the Consolidated Financial Statements
  • Company Statement of Financial Position
  • Company Statement of Changes in Shareholders' Equity
  • Notes to the Company Financial Statements
  • Financial History
  • Glossary
  • Shareholder Information
  • Advisers
  • Site Map
  • Accessibility
  • Cookies
  • Downloads
  • PDF Basket
  • Pipeline Delivery
  • Portfolio Focus
  • Geographical Expansion
  • Acquisition
Dechra Pharmaceuticals PLC
  • Strategic Report
    • Welcome to Dechra Pharmaceuticals PLC
    • The Global Market Opportunity
    • Dechra's Strengths
    • Highlights
    • Our Business Model
    • Our Business Model Explained
    • Our Products
    • Delivering Our Strategy
    • Geographical Footprint
    • Non-Executive Chairman's and Chief Executive Officer's Statement
    • Financial Review
    • Q&A with Ian Page
    • Q&A with Richard Cotton
    • Key Performance Indicators
    • Strategy in Action
      • Pipeline Delivery
      • Portfolio Focus
      • Geographical Expansion
      • Acquisition
    • Product Development
    • International Product Offering
    • Corporate Social Responsibility
    • How the Business Manages Risk
    • Understanding Our Key Risks
  • Our Governance
    • Letter from the Chairman on Governance
    • Corporate Governance
    • Letter from the Audit Committee Chairman
    • Audit Committee Report
    • Letter from the Nomination Committee Chairman
    • Letter from the Remuneration Committee Chairman
    • Directors' Remuneration Report
    • Directors' Report - Other Disclosures
    • Statement of Directors' Responsibilities
  • Our Financials
    • Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC
    • Consolidated Income Statement
    • Consolidated Statement of Comprehensive Income
    • Consolidated Statement of Financial Position
    • Consolidated Statement of Changes in Shareholders' Equity
    • Consolidated Statement of Cash Flows
    • Notes to the Consolidated Financial Statements
    • Company Statement of Financial Position
    • Company Statement of Changes in Shareholders' Equity
    • Notes to the Company Financial Statements
    • Financial History
  • Shareholder Information
    • Glossary
    • Shareholder Information
    • Advisers

Annual Report and Accounts for the year ended 30 June 2018

Our Financials Banner

3. Finance Income

  • Home
  • Our Financials
  • Notes to the Consolidated Financial Statements
  • 3. Finance Income
  • Page Previous Navigation Page Previous Navigation
  • Page Next Navigation Page Next Navigation
2018
£m		2017
£m
Finance income arising from:
— Cash and cash equivalents0.20.2
— Foreign exchange gains1.30.6
1.50.8
  • prev 2. Operating Segments
  • next 4. Finance Expense
Top

Site Essentials

  • Site Map
  • Accessibility
  • Cookies

© 2018 Dechra Pharmaceuticals PLC
www.dechra.com

Designed & developed by
Jones and Palmer